2 completed, 1 unknown. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Completed 2, Unknown 1 |
Follow Post-Concussion Syndrome: new trials by email Literature Review of Post-Concussion Syndrome trials Research Report on Post-Concussion Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Growth Hormone Deficiency in Mild Traumatic Brain Injury Growth Hormone, Placebo - Growth Hormone Treatment, Growth Hormone Deficiency | Early Phase 1 | Unknown | University of Calgary | 20 | 2023-02-01 | 2022-12-21 |
| A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents Magnesium Oxide, Acetaminophen, Zofran ODT 4 MG Disintegrating Oral Tablet - Concussion Post Syndrome | Early Phase 1 | Completed | Corewell Health South | 17 | 2017-09-01 | 2024-11-29 |
| The Effectiveness of Osteopathic Manipulative Medicine in the Management of Headaches Associated With Post Concussion Syndrome Osteopathic Manipulative Therapy - Headache, Post-Concussion Syndrome | Early Phase 1 | Completed | Hackensack Meridian Health | 26 | 2017-08-01 | 2021-05-25 |
Brain Concussion (1) · Dwarfism, Pituitary (1) · Headache (1)
Craniocerebral Trauma (3) · Head Injuries, Closed (3) · Nervous System Diseases (3) · Trauma, Nervous System (3) · Wounds and Injuries (3) · Wounds, Nonpenetrating (3) · Brain Concussion (2) · Bone Diseases (1) · Bone Diseases, Developmental (1) · Bone Diseases, Endocrine (1) · Brain Diseases (1) · Brain Injuries (1) · Brain Injuries, Traumatic (1) · Central Nervous System Diseases (1) · Dwarfism (1)
Acetaminophen (1) · Growth Hormone (1) · Magnesium Oxide (1) · Manipulation, Osteopathic (1) · Ondansetron (1)
Corewell Health South (1) · Hackensack Meridian Health (1) · University of Calgary (1)
United States (2)
Alphonsa Thomas, DO (1) · Chantel T Debert, MD, MSc (1) · Christopher Trigger, MD, CAQSM (1)